Factsheet: About the Value Added Medicines Group

White Paper: Tailoring Healthcare for Europe: The Strategy of Investing in Value Added Medicines

EU Public Procurement – Communications & Policy Toolkit

Memo on Cardiovascular Diseases Management

Position paper on the Biotech Act

Open letter on Strengthening Ukraine’s Pharmaceutical Regulatory System through the Establishment of the New National Competent Authority

Medicines for Europe’s comment on the CJEU Referral on the Export Exemption (Case C-371/26)

MEMO on a competitiveness strategy for the European healthcare sector

Review of the SPC Manufacturing Waiver: a 2026 Industry Report

Recommendations to National Authorities on the Use of External Reference Pricing (ERP)